IVF: Process, Success Rates, and Risks

In vitro fertilization is one of the most powerful and versatile tools in modern reproductive medicine. For couples whose fertility challenges have not responded to simpler approaches, or for those whose specific situations make IVF the most direct path to pregnancy, the technology offers a real chance of achieving the family they are working to build. The trajectory of IVF over the past several decades has been remarkable, transforming what was once an experimental procedure into a routine treatment that has produced millions of pregnancies worldwide.

Despite its prominence in fertility care, IVF is often misunderstood. The popular image of the procedure ranges from a simple medical fix that solves any fertility problem to an extreme intervention reserved only for the most difficult cases. The reality is more nuanced. IVF is a multistep process that involves substantial commitment, has variable success rates depending on individual factors, carries real but generally manageable risks, and is most appropriately used in specific clinical situations rather than as a universal first-line treatment.

For couples considering IVF, understanding what the process actually involves, what success rates can realistically be expected, what risks deserve attention, and when the treatment is most appropriate supports informed decisions. The technology has matured to the point where its strengths and limitations are well-characterized, and the available data provide a reliable foundation for thinking about whether and how to pursue treatment.

This article explains the IVF process step by step, the factors that determine success, the risks involved, and the situations in which IVF is typically recommended.

For more on the broader spectrum of fertility care, see Understanding Fertility Treatments: From Initial Testing to IVF and Advanced Reproductive Care.

What IVF Is

In vitro fertilization is a procedure in which eggs are retrieved from the ovaries, combined with sperm in the laboratory to allow fertilization, and the resulting embryos are transferred to the uterus. The Latin phrase "in vitro" means "in glass," reflecting that the fertilization occurs in laboratory glassware rather than within the body.

The technology was first developed in the 1970s, with the first IVF baby, Louise Brown, born in 1978. Since then, the procedure has been refined substantially. Modern IVF involves sophisticated laboratory techniques, careful hormonal management of the cycle, and various add-on technologies that have expanded what the procedure can accomplish.

The fundamental concept of IVF is that the limiting steps of natural conception, including egg release, fertilization, and embryo transport to the uterus, can be assisted or replaced through medical and laboratory intervention. The technology bypasses many of the steps where natural conception can fail, providing a powerful approach for couples whose fertility issues prevent successful natural conception.

When IVF Is Used

IVF is appropriate for many specific situations, with the indications having expanded substantially over the years.

Tubal Disease

For women with severe tubal disease, including bilateral tubal blockage or extensive scarring, IVF directly bypasses the affected anatomy. The fallopian tubes are not required for IVF, since fertilization occurs outside the body and embryos are placed directly in the uterus. For couples with isolated tubal factor infertility, IVF often produces favorable outcomes.

Severe Male Factor Infertility

For couples in whom the male partner has very low sperm count, severely reduced motility, or sperm production issues that prevent natural fertilization, IVF with intracytoplasmic sperm injection has transformed treatment possibilities. The technique can achieve fertilization with very few sperm, including sperm retrieved surgically from men with no sperm in the ejaculate.

Endometriosis

For women with severe endometriosis affecting fertility, IVF often provides the most direct path to pregnancy. The condition can affect multiple aspects of conception, and IVF bypasses many of the affected steps.

Diminished Ovarian Reserve

For women with reduced ovarian reserve, particularly when combined with advancing age, IVF allows attempts at conception with whatever eggs can be retrieved in a single stimulated cycle.

Failed Lower-Level Treatments

For couples who have not conceived with simpler treatments, including ovulation induction and intrauterine insemination, IVF often becomes the appropriate next step. The progression through treatment levels typically reaches IVF after several unsuccessful cycles of less complex approaches.

Unexplained Infertility

For couples in whom thorough evaluation has not identified a specific cause of fertility difficulty, IVF often becomes appropriate after failed attempts at less complex treatments.

Genetic Conditions

For couples at risk of having children with specific genetic conditions, IVF combined with preimplantation genetic testing allows selection of unaffected embryos before transfer.

Fertility Preservation

For people facing treatments that may affect future fertility, including chemotherapy or radiation, IVF can be used to create embryos for storage, providing future options.

For more on when IVF is appropriate, see Understanding Fertility Treatments: From Initial Testing to IVF and Advanced Reproductive Care.

The IVF Process Step by Step

A complete IVF cycle involves several specific phases over the course of approximately two to three weeks.

Pretreatment Evaluation

Before beginning IVF, comprehensive evaluation establishes baseline ovarian reserve, identifies any conditions that warrant attention, and develops the treatment plan. Common pretreatment assessments include hormonal testing, transvaginal ultrasound, semen analysis for the male partner, infectious disease screening, genetic carrier screening, and review of any specific factors that may affect treatment.

Ovarian Stimulation

The active treatment cycle typically begins with ovarian stimulation. The goal is to develop multiple follicles simultaneously, producing multiple eggs in a single retrieval rather than the single egg released in a natural cycle.

Stimulation typically involves daily injections of gonadotropin medications, including FSH and sometimes LH, for approximately 8 to 12 days. To prevent premature ovulation, GnRH antagonists or GnRH agonists are used depending on the specific protocol.

Monitoring during stimulation tracks follicular development through ultrasound and hormonal testing, typically every two to three days.

Trigger Injection

When follicles have developed to appropriate size, a trigger injection prompts final maturation of the eggs. The most common triggers are human chorionic gonadotropin (hCG) or a GnRH agonist. The trigger is typically administered approximately 36 hours before scheduled egg retrieval.

Egg Retrieval

Egg retrieval is performed approximately 36 hours after the trigger injection. The procedure is typically done under intravenous sedation in an outpatient setting and lasts approximately 15 to 30 minutes.

A needle guided by transvaginal ultrasound is passed through the vaginal wall into each ovary, and follicular fluid is aspirated from each mature follicle. Recovery is generally rapid, with most women returning home within an hour or two.

Fertilization

Fertilization occurs in the laboratory shortly after egg retrieval. Two main approaches are used.

Standard IVF involves placing eggs and sperm together in the laboratory, allowing fertilization to occur naturally. The approach is appropriate for couples without significant male factor issues.

Intracytoplasmic sperm injection (ICSI) involves injecting a single sperm directly into each egg. The technique is used for severe male factor infertility, prior fertilization failure, surgically retrieved sperm, or various other specific situations.

Both approaches typically achieve fertilization in approximately 60 to 80 percent of mature eggs.

Embryo Culture and Development

Fertilized eggs are cultured in the laboratory for several days. By day 3, embryos typically have 6 to 8 cells. By day 5 to 6, embryos that continue developing normally reach the blastocyst stage with approximately 100 cells. Most modern IVF programs prefer blastocyst-stage transfer, when development to that point provides selection benefit.

Not all embryos that begin developing reach the blastocyst stage. The attrition through development is one reason that eggs retrieved often outnumber embryos available for transfer.

Embryo Transfer

Embryo transfer involves placement of one or more embryos into the uterus through a thin catheter passed through the cervix. The procedure is typically brief, often lasting 5 to 10 minutes, and does not require anesthesia.

Modern IVF practice typically favors single embryo transfer to minimize multiple pregnancy risk. After transfer, women typically return home and resume normal activities within hours.

Luteal Phase Support

After embryo transfer, progesterone supplementation maintains the uterine environment for implantation. Support continues through approximately 10 to 12 weeks of pregnancy if implantation is successful.

Pregnancy Test

A blood pregnancy test is typically performed approximately 10 to 14 days after embryo transfer. A positive test confirms initial pregnancy. Subsequent monitoring including additional hCG levels and ultrasound establishes early viability.

Frozen Embryo Cycles

Embryos not transferred fresh can be frozen for use in future cycles. Frozen embryo transfer involves preparing the uterus through hormonal medications, then thawing and transferring stored embryos. Frozen embryo cycles produce comparable or sometimes slightly better outcomes than fresh transfers.

What Determines IVF Success

Multiple factors influence IVF outcomes, with maternal age being the most important.

Maternal Age

The single most important predictor of IVF success is the woman's age. Per-cycle live birth rates with the woman's own eggs are typically around 40 percent in women under 35, declining progressively to single digits in women in their mid 40s. The decline reflects primarily the decline in egg quality with age.

For more detail, see IVF Success Rates by Age: What the Data Actually Shows.

Cause of Infertility

The specific cause of fertility difficulty affects expected outcomes. Tubal factor and severe male factor with ICSI typically produce favorable outcomes for the woman's age. Diminished ovarian reserve produces more variable outcomes.

Embryo Quality

The quality of embryos produced influences implantation rates. High-quality embryos have higher implantation rates than lower-quality ones.

Endometrial Receptivity

The uterine lining must be receptive to allow implantation. Various factors affect endometrial receptivity, including hormonal conditions and anatomical factors such as fibroids or polyps.

Lifestyle Factors

Smoking substantially reduces IVF success rates. Body weight at either extreme can affect outcomes.

For more on these factors, see Lifestyle Factors That Affect Fertility.

Risks of IVF

IVF carries real but generally manageable risks.

Ovarian Hyperstimulation Syndrome

Ovarian hyperstimulation syndrome (OHSS) is the most significant risk specific to IVF. Mild OHSS is common and usually resolves on its own. Moderate OHSS produces more substantial symptoms including bloating, nausea, and discomfort. Severe OHSS, while uncommon, can produce dangerous fluid shifts, blood clots, and other serious complications requiring hospitalization.

Modern stimulation protocols have reduced the risk of severe OHSS substantially through GnRH antagonist protocols, GnRH agonist triggers in selected cases, and freezing all embryos with delayed transfer in high-risk cycles.

Egg Retrieval Complications

Egg retrieval is generally safe but carries specific risks including bleeding, infection, and rare damage to nearby structures. Anesthesia-related complications can occur as with any procedure under sedation.

Multiple Pregnancy

Multiple pregnancy has been a historic risk of IVF when multiple embryos were transferred. Multiple pregnancies carry substantially increased risks for both mother and babies. Modern IVF practice favors single embryo transfer for most situations, substantially reducing multiple pregnancy rates.

Ectopic Pregnancy

Ectopic pregnancy can occur after IVF as it can after natural conception. The risk after IVF is somewhat elevated compared to natural conception, particularly in women with prior tubal disease.

Emotional and Financial Burden

Beyond medical risks, the emotional and financial burden of IVF deserves recognition. The cumulative effect of cycles, waiting periods, uncertainty, and significant costs produces substantial psychological burden for many couples.

Cost and Access

IVF costs vary substantially among regions, clinics, and specific cycle types. Insurance coverage varies widely. For couples considering IVF, understanding the financial dimensions is part of decision-making. Many fertility clinics offer payment plans, financing options, or income-based pricing.

The Emotional Dimension

The emotional dimension of IVF deserves attention alongside the medical aspects. Common emotional patterns include hope and anticipation in early phases, anxiety during waiting periods, and grief after unsuccessful cycles.

Most fertility clinics now integrate mental health support into their care. For couples experiencing significant distress, professional support is valuable.

Special Considerations

Preimplantation Genetic Testing

Preimplantation genetic testing for chromosomal abnormalities (PGT-A) and for specific genetic conditions (PGT-M) can be performed on embryos created through IVF. PGT can improve per-transfer outcomes by ensuring only chromosomally normal embryos are transferred, but it does not increase the total number of viable embryos available.

Donor Cycles

For situations in which conception with the couple's own gametes is not possible, donor sperm, donor eggs, or donor embryos can be used. Donor egg cycles produce live birth rates of typically around 50 percent per transfer regardless of recipient age.

Surrogacy

Gestational surrogacy involves another woman carrying a pregnancy on behalf of intended parents. Surrogacy is used when the intended mother cannot carry a pregnancy due to various medical conditions. The legal and ethical aspects vary among jurisdictions.

Choosing Whether to Pursue IVF

The decision to pursue IVF involves multiple considerations.

Medical indications determine whether IVF is the appropriate next step. For some couples, IVF is the most direct path from the start. For others, simpler approaches are appropriate first.

Age substantially affects both the appropriate timing of IVF and the expected outcomes. For older women, earlier progression to IVF may be appropriate given the time-sensitive nature of fertility decline.

Personal factors including emotional readiness, financial resources, and individual preferences all influence the decision.

Realistic expectations support better experiences. Per-cycle success rates are meaningful but not certain. Most couples who pursue IVF eventually achieve their goals, though the path varies.

For more on expected outcomes, see IVF Success Rates by Age: What the Data Actually Shows.

Choosing a Clinic

Several factors deserve consideration when choosing a clinic. Experience and volume matter — high-volume clinics typically have well-developed laboratory capabilities and experienced practitioners. Standardized outcome data from national registries, when available, allow meaningful comparison. Communication and support systems affect the overall experience substantially.

When IVF Is Not Successful

Single cycle failure is common and does not necessarily indicate that IVF will not eventually succeed. After several unsuccessful cycles, comprehensive review of the treatment approach is appropriate. For couples in whom IVF with their own gametes does not succeed, donor options or other alternatives may be considered.

For some couples, the decision to stop treatment and pursue other paths to parenthood, including adoption or living without biological children, may become the right choice. These decisions are individual and deserve thoughtful consideration with appropriate support.

Conclusion

IVF is one of the most powerful tools in modern reproductive medicine, with the capacity to produce successful pregnancies for couples whose fertility issues prevent natural conception. The technology has matured substantially, with outcomes that are well-characterized through extensive clinical experience and registry data.

The practical approach for couples beginning to think about IVF involves comprehensive evaluation to establish the appropriate timing and approach, engagement with experienced specialists, attention to modifiable factors that support outcomes, realistic expectations about the typical course of treatment, and engagement with appropriate emotional support throughout.

Modern IVF can achieve favorable outcomes for the majority of couples who pursue it. The journey may be long, particularly for older women or for couples facing specific challenges, but the available paths typically produce meaningful chances of success.

For more on broader fertility topics, see How to Get Pregnant: Complete Guide and Understanding Fertility Treatments: From Initial Testing to IVF and Advanced Reproductive Care.

This content is for informational purposes only and does not constitute medical advice. Individuals should consult a qualified healthcare provider for diagnosis and treatment.